That's pretty much what most health authorities are saying though if you read more than 5 words of their statements? Starting with the AZ problems (which obviously weren't a thing in the US since it just stockpiled AZ, but a big topic in Europe) it's pretty much always has been "problems are rare, we continue to recommend it based on the benefit being way larger than the risk" (except in the countries that decided they don't evaluate it that way and restricted/stopped use). Same now with myocarditis. And promptly the complaints shift to "they are lying, the numbers are actually way worse than they say!".